Link Between Rheumatoid Arthritis & Lung Disease Request More Information Trial Objective The purpose of this study is to determine the development and progression of rheumatoid arthritis -associated lung disease (RA-LD) over time and to learn about the body’s generation of auto-antibodies in the blood. Researchers are trying to understand who develops rheumatoid arthritis (RA) and which RA patients go on to develop RA-LD, as well as how to prevent and treat the disease Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Individuals with rheumatoid arthritis (RA), interstitial lung disease (ILD) or lung fibrosis may be eligible to participate. Age: 18+ Gender: Any Gender Estimated Time Commitment 6 in-person visits, performed every year over 4 years × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Not Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Faduma Ahmed 303.398.1285 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Pfizer Principal Investigators Joshua Solomon, MD + × Joshua Solomon, MD Director, Interstitial Lung Disease Program Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Critical Care Medicine View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Co-Investigators Michael Mohning, MD + × Michael Mohning, MD Assistant Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective The purpose of this study is to determine the development and progression of rheumatoid arthritis -associated lung disease (RA-LD) over time and to learn about the body’s generation of auto-antibodies in the blood. Researchers are trying to understand who develops rheumatoid arthritis (RA) and which RA patients go on to develop RA-LD, as well as how to prevent and treat the disease